Aaron Dahl, MD
Psychiatry · Gilbert, AZNPI 1891172813
Payments from drug & device makers
Across 644 payments — averaging $18.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Corium, LLC$1K
- Otsuka America Pharmaceutical, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Ironshore Pharmaceuticals Inc.$747
- Axsome Therapeutics, Inc.$590
- plus $5K from 26 others
What the payments were for
- Food & beverage$11,49499%
- Education$1041%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 114 | $1,668 |
| Corium, LLC | 76 | $1,347 |
| Otsuka America Pharmaceutical, Inc. | 59 | $1,114 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 59 | $1,036 |
| Ironshore Pharmaceuticals Inc. | 45 | $747 |
| Axsome Therapeutics, Inc. | 30 | $590 |
| Sunovion Pharmaceuticals Inc. | 26 | $528 |
| Takeda Pharmaceuticals U.S.A., Inc. | 31 | $494 |
| Supernus Pharmaceuticals, Inc. | 23 | $482 |
| Lundbeck LLC | 21 | $465 |
| Almatica Pharma LLC | 23 | $416 |
| Tris Pharma Inc | 22 | $355 |
| Johnson & Johnson | 15 | $336 |
| Neurocrine Biosciences, Inc. | 16 | $332 |
| Alkermes, Inc. | 14 | $323 |
| Teva Pharmaceuticals USA, Inc. | 15 | $310 |
| Bausch Health US, LLC | 10 | $176 |
| Vanda Pharmaceuticals Inc. | 6 | $120 |
| Harmony Biosciences LLC | 5 | $112 |
| Biogen | 4 | $107 |
| Eisai Inc. | 5 | $102 |
| Collegium Pharmaceutical, Inc. | 5 | $100 |
| Noven Therapeutics, LLC | 4 | $65 |
| Idorsia Pharmaceuticals US Inc | 4 | $62 |
| Vertical Pharmaceuticals, LLC | 3 | $45 |
| Medtronic | 2 | $36 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Actelion Pharmaceuticals US, Inc. | 1 | $28 |
| Boston Scientific | 1 | $24 |
| Tempus AI, Inc | 1 | $17 |
| Neos Therapeutics, LP | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $11 |
How this compares
$11,598 in reported general payments places this provider in the 90th percentile of 573 psychiatry providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 12 | $58,572 |
| VyvanseLisdexamfetamine Dimesylate | 13 | $8,112 |
| Aripiprazole | 53 | $3,826 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 17 | $1,123 |
| Lamotrigine | 34 | $746 |
| Sertraline Hcl | 23 | $738 |
| Hydroxyzine Hcl | 18 | $706 |
| Oxcarbazepine | 14 | $702 |
| Trazodone Hcl | 36 | $618 |
| Bupropion XlBupropion Hcl | 26 | $517 |
| Mirtazapine | 28 | $499 |
| Duloxetine Hcl | 50 | $390 |
| Clonazepam | 56 | $368 |
| Quetiapine Fumarate | 24 | $336 |
| Methylphenidate Hcl | 17 | $324 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $310 | $58,57212 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $494 | $8,11213 claims |
| Almatica Pharma LLCSertraline Hcl | $416 | $73823 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 573 psychiatry providers in Arizona.
Other psychiatry in Gilbert
- Richard BurtonGilbert$14K
- Justin McKinleyGilbert$6K
- Jason CaplanPhoenix$999K
- Thomas GazdaPhoenix$714K
- Katherine KelleyChandler$610K
- Payam SadrMesa$487K
- Steven BuppTucson$451K
- Monica BenavidezPhoenix$435K
- Ahmed ElmaadawiPhoenix$395K
- Lee KelleyPhoenix$340K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.